Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AZN compared with NDAQ: revenue, margins and what each company keeps, and the suppliers and customers both name
AZN
Astrazeneca PLC
Change
Mkt cap
Revenue
Revenue
NDAQ
Nasdaq, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
AZN
Astrazeneca PLC
vs
NDAQ
Nasdaq, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only AZN
20
ARQT
Arcutis Biotherapeutics
customer
GRAL
Grail
supplier
RCUS
Arcus Biosciences
customer
NKTR
Nektar Therapeutics
supplier
16 more · AZN chain
›
Shared
0
No shared counterparties.
Only NDAQ
25
HOOD
Robinhood Markets
customer
UMBF
UMB Financial
customer
COLB
Columbia Banking System
customer
TCBI
Texas Capital Bancshares
customer
Role chip = supplier or customer
Source: SEC EDGAR
21 more · NDAQ chain
›
AZN
Astrazeneca PLC
Change
186.20
▼
−0.35%
· post 187.60
Mkt cap
$289.1B
Revenue
—
Revenue
—
NDAQ
Nasdaq, Inc.
Change
107.12
▲
+0.27%
· post 107.11
Closed
Nov 6 '26
Mkt cap
$59.3B
Revenue
$2.4B
Q3 FY26
Revenue
$8.3B
FY25
vs
Compare
Closed
Nov 6 '26
AZN
Astrazeneca PLC
vs
NDAQ
Nasdaq, Inc.
186.20
▼
−0.35%
post 187.60
Price
107.12
▲
+0.27%
post 107.11
$289.1B
Mkt cap
$59.3B
—
Revenue
$2.4B
Q3 FY26
—
Revenue
$8.3B
FY25
Change
Change
AZN
186.20
▼
−0.35%
vs
NDAQ
107.12
▲
+0.27%
Closed
Nov 6 '26